These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21529270)

  • 21. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2006 Dec; 48(6):926-34. PubMed ID: 17162147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.
    Recio-Mayoral A; Banerjee D; Streather C; Kaski JC
    Atherosclerosis; 2011 Jun; 216(2):446-51. PubMed ID: 21414625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between serum free fatty acid and cytokines, carotid atherosclerosis in chronic kidney disease].
    Wu BB; Zhang LM; Mei CL; Tang Q; Lu YZ
    Zhonghua Nei Ke Za Zhi; 2010 Jul; 49(7):572-6. PubMed ID: 20979766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Saglam M; Caglar K; Verim S; Unal HU; Gok M; Demirkaya E; Gaipov A; Kayrak M; Cetinkaya H; Eyileten T; Turk S; Vural A
    Am J Med Sci; 2014 Feb; 347(2):118-24. PubMed ID: 23928544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in endothelial function in chronic kidney disease.
    Kruse NT; You Z; Moreau K; Kendrick J; Jalal D
    Am J Physiol Renal Physiol; 2020 Jul; 319(1):F33-F40. PubMed ID: 32421350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease.
    Koivuviita N; Tertti R; Järvisalo M; Pietilä M; Hannukainen J; Sundell J; Nuutila P; Knuuti J; Metsärinne K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2773-9. PubMed ID: 19369689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure.
    Cross JM; Donald AE; Nuttall SL; Deanfield JE; Woolfson RG; Macallister RJ
    Kidney Int; 2003 Apr; 63(4):1433-42. PubMed ID: 12631359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein oxidation in chronic kidney disease.
    Caimi G; Carollo C; Hopps E; Montana M; Lo Presti R
    Clin Hemorheol Microcirc; 2013; 54(4):409-13. PubMed ID: 23719419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer.
    Miyazaki H; Matsuoka H; Itabe H; Usui M; Ueda S; Okuda S; Imaizumi T
    Circulation; 2000 Mar; 101(9):1002-6. PubMed ID: 10704167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interrelationship between endothelial dysfunction, IMT of the carotid arteries and adhesion molecules in obese hypertensive children and adolescents].
    Głowińska-Olszewska B; Tołwińska J; Urban M
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):7-14. PubMed ID: 17493400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
    Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial function, CRP and oxidative stress in chronic kidney disease.
    Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
    J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
    Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
    Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients.
    Sahin G; Yalcin AU; Akcar N
    Blood Purif; 2007; 25(4):309-15. PubMed ID: 17643057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in antioxidant status associated with haemodialysis in chronic kidney disease.
    Ogunleye A; Akinbodewa AA; Adejumo OA; Oluwafemi TT; Akinfaderin DA
    Ghana Med J; 2018 Mar; 52(1):29-33. PubMed ID: 30013258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ultrasonographic study on effects of Wendan Xiezhuo method in improving vascular endothelial diastolic function and atherosclerosis in hypertension patients with turbid-phlegm syndrome].
    Zhao P; Chen J; Hong YD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan; 27(1):21-4. PubMed ID: 17302058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
    Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
    Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
    Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.